发明名称 |
DIARYL-HARNSTOFFE MIT KINASEHEMMENDER WIRKUNG |
摘要 |
The present invention provides methods of using aryl ureas to treat diseases and conditions associated with signal transduction pathways comprising at least one of raf, VEGFR, PDGFR, p38 and/or FLT-3. The present invention also provides compositions and methods for identifying conditions and diseases which can be modulated with compounds of the present invention. These methods facilitate the selection of subjects who can be efficiently treated with compounds of the present invention. Additionally, the invention provides methods for monitoring subjects who have been administered a compound of the present invention. |
申请公布号 |
DE602004011340(D1) |
申请公布日期 |
2008.03.06 |
申请号 |
DE20046011340T |
申请日期 |
2004.05.19 |
申请人 |
BAYER PHARMACEUTICALS CORP. |
发明人 |
WILHELM, SCOTT;DUMAS, JACQUES;LADOUCEUR, GAETAN;LYNCH, MARK;SCOTT, WILLIAM J. |
分类号 |
G01N33/574;A61K31/00;A61K31/4412;A61K31/4418;A61K31/443;A61K45/06;A61L31/16 |
主分类号 |
G01N33/574 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|